HK-Shenzhen pulls off a first under medical connect

    By Chai Hua | HK EDITION | Updated: 2021-05-21 14:26
    Share
    Share - WeChat
    Management teams from the University of Hong Kong-Shenzhen Hospital and China Resources Guangdong Pharmaceutical pose for a group photo with the first imported medicine and medical device under the connect on April 16. [Photo provided to China Daily]

    Moreover, he said the new channel can expand sales of medical companies. The hospital is purchasing a further 10 titanium rods. Each patient needs only one or two rods.

    Lo said safety concerns will ensure the quantity won't be extremely large initially. "The titanium rod producer has agreed to provide the equipment on the mainland because they knew Professor Cheung would perform the surgery," he added, stressing the result of each case is important for the drug and medical equipment producers.

    According to HKU-SZH, four other innovative medications have been approved and will soon be put into pilot use at the hospital, following the first drug and device applications.

    The first imported medicine under the connect program is Rho(D) immune globulin - a blood disease drug that was used clinically at the hospital on April 29. In addition, the clinical data collected from these applications could also help expedite national approval for related international drugs or devices.

    The marketing of many medicines in Hong Kong is synchronized with the world because of mutual recognition, but the mainland needs to do its own clinical results for review and approval, said Huo Peiqiong, general manager of China Resources Guangdong Pharmaceutical - the import agent for the first drugs and equipment.

    So registering in Hong Kong or launching the products in the Hong Kong market is much faster than on the mainland, she noted. For example, one drug can be listed in Hong Kong simultaneously in the United States or the United Kingdom.

    The connect gives the green light for medicines that are already available in Hong Kong and Macao markets, so more international pharmaceutical enterprises would seek registration there because entering the two special administrative regions mean they could tap the Greater Bay Area or the entire mainland market sooner.

    However, it wasn't plain sailing for reviewing, purchasing and transporting the first batch of drugs and device through the connect. Huo recalled it took more than two months to have them delivered.

    Many innovative measures were needed to lay a solid foundation for the potential expansion of the connect to more mainland cities. But in the absence of national approval, the import agent had to communicate back and forth between local evaluation authorities and pharmaceutical enterprises to provide proper materials for review.

    |<< Previous 1 2 3 4 Next   >>|
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    久久久久亚洲精品无码蜜桃| 无码毛片一区二区三区中文字幕 | 老司机亚洲精品影院无码 | 久久人妻AV中文字幕| 亚洲av无码成人黄网站在线观看| 中文字幕AV一区中文字幕天堂| 无码AV中文一区二区三区| 亚洲中文字幕无码专区| 一本大道无码日韩精品影视| 人妻丰满熟妇岳AV无码区HD| 精品欧洲av无码一区二区14| 波多野结衣在线aⅴ中文字幕不卡| av无码一区二区三区| 无码中文人妻在线一区二区三区| 中文无码一区二区不卡αv| 狠狠干中文字幕| 欧美日韩国产中文高清视频| 无码任你躁久久久久久久| 久久综合精品国产二区无码| 亚洲Av永久无码精品三区在线 | 最近最新高清免费中文字幕 | 无码精品第一页| 国产精品无码永久免费888| 精品无码人妻一区二区三区品 | 精品视频无码一区二区三区| 亚洲va无码专区国产乱码| 一本大道东京热无码一区| 精品无码一区二区三区在线| 日韩免费在线中文字幕| xx中文字幕乱偷avxx| 亚洲欧洲中文日韩久久AV乱码 | 免费无码又爽又刺激一高潮| 中文字幕精品久久| 蜜桃臀AV高潮无码| 亚洲日韩国产AV无码无码精品| 最新国产精品无码| 亚洲精品午夜无码专区| 无码中文av有码中文a| 少妇无码AV无码专区线| AA区一区二区三无码精片| 色欲香天天综合网无码|